摘要
Cancer immunotherapy has emerged as a promising approach in cancer treatment and is considered a major advancement after surgical interventions, radiotherapy, chemotherapy, and targeted therapy. The clinical use of immunotherapeutic drugs, particularly antibody-based drugs that target immune checkpoints, has notably increased~1.
基金
supported by grants from the National Natural Science Foundation of China (Grant No. U20A20369)
GuangDong Basic and Applied Basic Research Foundation (Grant No. 2022B1515120085)。
